<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 08 Nov 2009 23:08:11 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Value Investing</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3264165</guid>
      <description><![CDATA[All companies listed below met The Applied Finance Group's (AFG's) Buy screen criteria and are in the bottom half of their sector in Market Value/Invested Capital (MV/IC), which by definition qualifies the companies as part of the AFG Value Universe. When identifying buy ideas, AFG looks for companies with the most valuation upside compared to their sector peers, above sector median expected Economic Margin change, and a management quality score that reflects a management team following a wealth creating strategy.    &#160;  9 Value Companies To Watch            A brief description of AFG's buy criteria variables:     AFG's Valuation<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3264165>[More...]</a>]]></description>
      <pubDate>Wed, 10 Jun 2009 13:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APOL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GME</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HRS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WAT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3264165</link>
    </item>
    <item>
      <title>Earnings Preview &amp; Review: LLL, AMTD, RSH, PDS, POT, NYT, HOT, BG, BDK, RX, DO, LLY, RTN</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2732119</guid>
      <description><![CDATA[Some of the market movers are likely to turn Wall Street volatile with mixed earnings reports as the companies emerge from the financial crisis in September and 16-month long credit crunch.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2732119>[More...]</a>]]></description>
      <pubDate>Thu, 23 Oct 2008 12:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMTD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BDK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HOT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NYT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PDS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RSH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RTN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2732119</link>
    </item>
    <item>
      <title>Sunday Thoughts for July 20th 2008</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2414166</guid>
      <description><![CDATA[Working on tonight’s commentary. Check back later tonight.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2414166>[More...]</a>]]></description>
      <pubDate>Mon, 21 Jul 2008 06:44:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AAPL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AME</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ARTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ASTE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CACH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRNT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DSL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EFX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EXP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FWRD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GBE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HIFN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HPC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HXL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LNCR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LOGI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MHK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MSPD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OMCL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OMI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PETS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PGI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PKG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QLGC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RGA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RPM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SFG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNDK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VLTR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WGOV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ZRAN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2414166</link>
    </item>
    <item>
      <title>IMS Health (NYSE:RX): Color on quarter</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/522395</guid>
      <description><![CDATA[Baird comments on IMS Health (NYSE:RX) after the co released its Q2 results last night:- Firm notes 2Q results met but were hindered by unexpected European sales challenges, preventing sales upside and limiting margin somewhat surprising following the bullish May 24 IR event.Revenue variance vs. firm's model was primarily Sales Force Effectiveness performance, resulting from unexpected June-end timing and sales execution delays in Europe, primarily U.K. and Germany, as clients responded to challenging reimbursement and regulatory events, by refocusing marketing efforts. IMS has introduced...<a href=http://www.istockanalyst.com/article/viewarticle/articleid/522395>[More...]</a>]]></description>
      <pubDate>Thu, 19 Jul 2007 13:34:21 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/522395</link>
    </item>
    <item>
      <title>Companies Reporting After Close (07/18/2007)- Part 3</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/517714</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/517714>[More...]</a>]]></description>
      <pubDate>Wed, 18 Jul 2007 14:12:15 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ISIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVEC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCBI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TER</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TMK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WAL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WSBC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/517714</link>
    </item>
    <item>
      <title>IMS Health bought for $5.2 billion</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3615529</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 6--IMS Health Inc., which provides market research to the  pharmaceutical and health-care industries, said yesterday that it agreed to be  acquired for $5.2 billion, including the assumption of debt. &lt;/li&gt;&lt;li&gt;The buyers are private-equity firm TPG Capital and the investment board  of the Canada Pension Plan. &lt;/li&gt;&lt;li&gt;It expects about 170 of those dismissals to occur  in the United States.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3615529>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 21:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRIN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3615529</link>
    </item>
    <item>
      <title>IMS Health Sold For $5.2 Billion</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3613162</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 6--Norwalk-based IMS Health, a provider of health care data, said Thursday that it will be acquired by two private investment funds in a deal valued at $5.2 billion, sending its shares soaring 23 percent. &lt;/li&gt;&lt;li&gt;An IMS spokesman declined to comment whether there would further job cuts as a result of the company's sale. &lt;/li&gt;&lt;li&gt;IMS, founded in 1954, will be taken private by TPG Capital and the CPP Investment Board in a deal structured as a leveraged buyout in cash and debt.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3613162>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 07:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3613162</link>
    </item>
    <item>
      <title>Business Highlights</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3612195</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;October sales offer relief to merchants&lt;/li&gt;&lt;li&gt;NEW YORK (AP) - Stores are heading into the period with slashed inventories, determined not to have the fire sales that characterized last Christmas. &lt;/li&gt;&lt;li&gt;Sales at stores open at least a year rose 2.1 percent in October, according to the International Council of Shopping Centers-Goldman Sachs tally, compared with a 4.2 percent drop in October 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3612195>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 21:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">C</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LCAPA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">T</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3612195</link>
    </item>
    <item>
      <title>CVS Caremark, Costco, Dynegy are big movers</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3612177</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - The following stocks were among those that moved substantially or traded heavily Thursday on the New York Stock Exchange:&lt;/li&gt;&lt;li&gt;Dr Pepper Snapple Group Inc., down $1.30 at $26.52&lt;/li&gt;&lt;li&gt;Its struggling Caremark pharmacy benefits management unit lost $2 billion in business over the last few months, the company said.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3612177>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 21:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DPS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DYN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3612177</link>
    </item>
    <item>
      <title>IMS Health to be bought for $4 billion by TPG, CPP</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610240</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NORWALK, Conn. - Health care data company IMS Health Inc. said Thursday it is being bought by investment funds TPG Capital and CPP Investment Board for $4 billion.&lt;/li&gt;&lt;li&gt;IMS shareholders are getting $22 per share under the deal, marking a 31 percent premium to the stock's closing price of $16.81 on Wednesday.&lt;/li&gt;&lt;li&gt;The company, based in Norwalk, Conn., said the deal is valued at $5.2 billion including the assumption of debt.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610240>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 14:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610240</link>
    </item>
    <item>
      <title>Drug Sales Forecast to Rise: Researcher IMS Health Says Global Sales Will Hit $825 Billion in 2010.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3537421</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 8--Pharmaceutical sales are expected to pick up slightly next year despite the torpid economy and accelerating competition from generic drugs, a prominent industry research firm said yesterday. &lt;/li&gt;&lt;li&gt;Pharmacies are stocking more products this year because the fear that economic turmoil would cause some patients to stop taking their medicines didn't prove true, said Murray Aitken, senior vice president of health-care insight at IMS. &lt;/li&gt;&lt;li&gt;Programs that help consumers get free prescriptions or subsidize co-payments may have been a factor, Aitken said.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3537421>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 07:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3537421</link>
    </item>
    <item>
      <title>Roche Deal Lifts SurModics Stock: Eden Prairie Firm Could Take in $200M</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3534201</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 7--Shares of Eden Prairie-based SurModics surged nearly 20 percent Tuesday on word of a licensing and development agreement with pharmaceutical giant Roche and its biotech subsidiary Genentech. &lt;/li&gt;&lt;li&gt;Under the agreement, Roche and Genentech have obtained an exclusive license to use a SurModics system to develop and commercialize a sustained drug delivery formulation of Lucentis, a widely used drug for patients with an eye disorder known as age-related macular degeneration. &lt;/li&gt;&lt;li&gt;The agreement provides Roche and Genentech with opportunities to develop compounds other than Lucentis for the treatment of eye diseases.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3534201>[More...]</a>]]></description>
      <pubDate>Wed, 07 Oct 2009 08:09:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3534201</link>
    </item>
    <item>
      <title>Lilly moves on from Prozac to Cymbalta</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3431902</guid>
      <description><![CDATA[Lilly moves on from Prozac to Cymbalta<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3431902>[More...]</a>]]></description>
      <pubDate>Mon, 24 Aug 2009 02:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3431902</link>
    </item>
    <item>
      <title>Ford, Chrysler Low on Small Cars</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3403068</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Aug. 8--Chrysler Group LLC and Ford Motor Co. are running low on their hottest-selling models under the cash for clunkers program, even as President Barack Obama signed authorization Friday of an additional $2 billion to extend the program. &lt;/li&gt;&lt;li&gt;Some Chrysler dealers are out of the Dodge Caliber, Dodge Avenger, Jeep Compass and Jeep Patriot. &lt;/li&gt;&lt;li&gt;&quot;We sold out a week ago,&quot; said Steve Demers, general manager of Cueter Chrysler Jeep Dodge in Ypsilanti.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3403068>[More...]</a>]]></description>
      <pubDate>Sat, 08 Aug 2009 14:59:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HMC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NSANY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3403068</link>
    </item>
    <item>
      <title>IMS Health Cuts Pharma Growth Forecast</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3204970</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Big Pharma isn't so immune to the recession after all. &lt;/li&gt;&lt;li&gt;In an indication the deterioration of the global economy is hitting drugmakers, a research group said on Apr. 22 that it's cutting a closely watched forecast for industry growth.&lt;/li&gt;&lt;li&gt;Global sales of pharmaceuticals will increase only 2.5% to 3.5% in 2009, down from a forecast for 4.5% to 5.5% growth issued in October, according to IMS Health (RX), which analyzes industry trends.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3204970>[More...]</a>]]></description>
      <pubDate>Thu, 23 Apr 2009 18:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3204970</link>
    </item>
    <item>
      <title>PicksThatMove.com Announces Investment Opinion On: IMS Health Inc, MetLife Inc., ON Semiconductor Corporation, Neohydro Technologies Corporation and WesternZagros Resources Ltd.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610476</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;PicksThatMove is pleased to bring investors special situation stocks   which have a high potential for price appreciation. &lt;/li&gt;&lt;li&gt;The investment opinions offered below and in this press release are   provided by Nick Hunter, RIA, of PicksThatMove.com&lt;/li&gt;&lt;li&gt;IMS Health Inc. (NYSE: RX), $20.76, +$3.95, 23.50%, is actively   trading this morning with gains of over 20% for a volume of 28.1 million   shares traded.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610476>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 16:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MET</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NHYT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ONNN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610476</link>
    </item>
    <item>
      <title>IMS Health to be Acquired by TPG and CPP Investment Board</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610088</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;IMS Health (NYSE: RX), the world's leading provider of market   intelligence to the pharmaceutical and healthcare industries, today   announced that it has entered into a definitive agreement to be acquired   by investment funds managed by TPG Capital (&quot;TPG&quot;) and the CPP   Investment Board (&quot;CPPIB&quot;) in a transaction with a total value of $5.2   billion, including the assumption of debt.&lt;/li&gt;&lt;li&gt;&quot;IMS Health has consistently demonstrated it is the definitive source   ofcritical data and servicesto the evolving healthcare industry,&quot;said   Jonathan Coslet, Senior Partner, TPG.&quot;We are pleased to join with our   long-time partner, CPP Investment Board, and a talented management team   to continue the growth of this outstanding franchise.&quot;&lt;/li&gt;&lt;li&gt;This information may involve risks and   uncertainties that could cause actual results of IMS Health to differ   materially from the forward-looking statements.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610088>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 13:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610088</link>
    </item>
    <item>
      <title>IMS Health Exploring Strategic Alternatives</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3566391</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;IMS Health (NYSE: RX), the world's leading provider of market   intelligence to the pharmaceutical and healthcare industries, today   announced that it is exploring a variety of strategic alternatives. &lt;/li&gt;&lt;li&gt;The   Company further stated that as part of the process the Board of   Directors has formed a committee, which has retained Foros Securities   LLC as its financial advisor. &lt;/li&gt;&lt;li&gt;The Company has retained Deutsche Bank   Securities Inc. as its financial advisor.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3566391>[More...]</a>]]></description>
      <pubDate>Tue, 20 Oct 2009 21:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3566391</link>
    </item>
    <item>
      <title>RidgewaterEquity.Com Free Fundamental Sector &amp;Amp; Market Research on AEG, ETR, LFC, RX, ARG and TD</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3537553</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;RidgewaterEquity.com inspires to bring the best from the internet under one roof, providing you with a one click option to view what the market, researchers and financial pundits worldwide have to say about any particular large cap stocks in any given financial environment. &lt;/li&gt;&lt;li&gt;Once you sign up as a free member you will have free unlimited access to all our reports, research tools and more.&lt;/li&gt;&lt;li&gt;We have recently begun in-depth analysis of the following equities &amp;amp; their respective sectors:&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3537553>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 10:05:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AEG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ARG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ETR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TD</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3537553</link>
    </item>
    <item>
      <title>IMS Health Launches &amp;#152;Ask IMS' to Help Early-Stage Biopharmaceutical Companies Enhance Business Development, Commercialization Strategies</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3503118</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;IMS Health (NYSE: RX) today announced the launch of Ask IMSTM,   a cost-effective, Web-based service that provides strategic market   intelligence to help drive the growth and success of early-stage   biopharmaceutical companies. &lt;/li&gt;&lt;li&gt;Drawn from IMS's comprehensive   pharmaceutical market information, Ask IMS offers timely   decision-making support for understanding critical market opportunities   and issues, as well as for planning and executing successful   commercialization strategies.&lt;/li&gt;&lt;li&gt;&quot;With more than 1,500 biopharmaceutical drugs in active development by   early-stage firms, companies are seeking evidence-based insights to   develop and integrate commercial thinking early on and throughout the   development process,&quot; said Jim Mahon, general manager, Product and   Portfolio Management, IMS.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3503118>[More...]</a>]]></description>
      <pubDate>Thu, 24 Sep 2009 13:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3503118</link>
    </item>
    <item>
      <title>IMS Appoints Don Otterbein General Manager, Business Transformation Services, to Lead Expanded Knowledge Process Outsourcing Initiative</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3484340</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;IMS Health (NYSE: RX), the world's leading provider of market   intelligence to the pharmaceutical and healthcare industries, today   announced that Donald G. Otterbein has been named general manager,   Business Transformation Services, a new role. &lt;/li&gt;&lt;li&gt;IMS is extending its Knowledge   Process Outsourcing (KPO) capabilities as clients seek new ways to drive   commercial excellence and more meaningful cost efficiencies in today's   dynamic healthcare environment.&lt;/li&gt;&lt;li&gt;&quot;At a time when pharmaceutical companies are looking for agility and   innovation in their business models, IMS is delivering powerful   expertise to help them transform their commercial operations and   processes,&quot; said Carlucci.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3484340>[More...]</a>]]></description>
      <pubDate>Wed, 16 Sep 2009 14:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3484340</link>
    </item>
    <item>
      <title>IMS Named to Dow Jones Sustainability North America Index</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3463666</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;IMS Health (NYSE: RX) has been named to the Dow Jones Sustainability   North America Index (DJSI North America), recognizing the company's   economic, environmental and social performance. &lt;/li&gt;&lt;li&gt;The Index identifies   companies that demonstrate leadership in sustainability among the   largest 600 North American companies in the Dow Jones Global Index.&lt;/li&gt;&lt;li&gt;&quot;We're very pleased to receive this recognition,&quot; said David R.   Carlucci, chairman and CEO, IMS.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3463666>[More...]</a>]]></description>
      <pubDate>Tue, 08 Sep 2009 16:08:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3463666</link>
    </item>
    <item>
      <title>BenchmarkJournal.Com Free Analyst Review for A, COG, SVU, DF, RX and AMR</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3414320</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities. &lt;/li&gt;&lt;li&gt;Today we began research on Agilent Technologies Inc. (NYSE: A), Cabot Oil &amp;amp; Gas Corp. (NYSE: COG), SUPERVALU Inc. (NYSE: SVU), Dean Foods Co. (NYSE: DF), IMS Health Inc. (NYSE: RX) and AMR Corporation (NYSE: AMR).&lt;/li&gt;&lt;li&gt;To view our research, sign up now and get started with your complimentary subscription.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3414320>[More...]</a>]]></description>
      <pubDate>Fri, 14 Aug 2009 12:08:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">A</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SVU</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3414320</link>
    </item>
    <item>
      <title>Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3400605</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;ARDEE, Ireland, Aug. 7  /PRNewswire-Firstcall/ -- Warner Chilcott Limited  today announced its results for the quarter ended June 30, 2009. &lt;/li&gt;&lt;li&gt;The Company reported net income of $56.0 million ($0.22 per diluted share) in the quarter ended June 30, 2009, compared with net income of $33.6 million ($0.13 per diluted share) in the prior year quarter, an increase of 66.9%. &lt;/li&gt;&lt;li&gt;Cash net income (&quot;CNI&quot;) in the quarter ended June 30, 2009 rose to $109.2 million ($0.44 per diluted share), an increase of 29.6% over the prior year quarter.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3400605>[More...]</a>]]></description>
      <pubDate>Fri, 07 Aug 2009 11:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WCRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3400605</link>
    </item>
    <item>
      <title>Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results and Operational Highlights</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3397223</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended June 30, 2009. &lt;/li&gt;&lt;li&gt;The net loss for the second quarter of 2009 was $(13.4) million, or $(0.32) per share, compared to a net loss of $(11.7) million, or $(0.29) per share, reported for the second quarter of 2008.&lt;/li&gt;&lt;li&gt;&quot;We believe that the second quarter of 2009 was a great success for Auxilium.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3397223>[More...]</a>]]></description>
      <pubDate>Thu, 06 Aug 2009 10:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3397223</link>
    </item>
    <item>
      <title>Form  4          Nelligan William          For: Nov 02 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3603531</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3603531>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 19:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3603531</link>
    </item>
    <item>
      <title>Form  4          WISE BRET W               For: Oct 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3599268</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3599268>[More...]</a>]]></description>
      <pubDate>Mon, 02 Nov 2009 19:59:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3599268</link>
    </item>
    <item>
      <title>Form  4          IMS HEALTH INC            For: Oct 19  Filed by: WISE BRET W (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3569891</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3569891>[More...]</a>]]></description>
      <pubDate>Wed, 21 Oct 2009 21:06:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3569891</link>
    </item>
    <item>
      <title>Form  4          IMS HEALTH INC            For: Oct 19  Filed by: CLEMENTE CONSTANTINE L (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3569892</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3569892>[More...]</a>]]></description>
      <pubDate>Wed, 21 Oct 2009 21:06:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3569892</link>
    </item>
    <item>
      <title>Form  4          ASHMAN HARVEY A.          For: Oct 01 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3529359</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3529359>[More...]</a>]]></description>
      <pubDate>Mon, 05 Oct 2009 21:14:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3529359</link>
    </item>
    <item>
      <title>Form  3          ASHMAN HARVEY A.          For: Oct 01 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3529360</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3529360>[More...]</a>]]></description>
      <pubDate>Mon, 05 Oct 2009 21:14:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3529360</link>
    </item>
    <item>
      <title>Form  4          WISE BRET W               For: Sep 29 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3517425</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3517425>[More...]</a>]]></description>
      <pubDate>Wed, 30 Sep 2009 22:35:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3517425</link>
    </item>
    <item>
      <title>Form  4          CLEMENTE CONSTANTINE L    For: Sep 29 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3517426</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3517426>[More...]</a>]]></description>
      <pubDate>Wed, 30 Sep 2009 22:35:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3517426</link>
    </item>
    <item>
      <title>Form  4          IMS HEALTH INC            For: Aug 21  Filed by: Kevin McKay S (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3432821</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3432821>[More...]</a>]]></description>
      <pubDate>Mon, 24 Aug 2009 19:28:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3432821</link>
    </item>
    <item>
      <title>Form  4          STEINFELD ROBERT H        For: Jul 31 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3393106</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3393106>[More...]</a>]]></description>
      <pubDate>Tue, 04 Aug 2009 22:07:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3393106</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=RX" rel="self" type="application/rss+xml" />
  </channel>
</rss>